Immunogenic profiling of Mycobacterium tuberculosis DosR protein Rv0569 reveals its ability to switch on Th1 based immunity-Reference-Cited by-同舟云学术

Immunogenic profiling of Mycobacterium tuberculosis DosR protein Rv0569 reveals its ability to switch on Th1 based immunity

Published:2022-02 Issue: Volume:242 Page:27-36
ISSN:0165-2478
Container-title:Immunology Letters
language:en
Short-container-title:Immunology Letters

Author:

Kanaparthi Kala Jyothi,Afroz Sumbul,Minhas Gillipsie,Moitra Anurupa,Khan Rafiq Ahmad,Medikonda Jayashankar,Naz Saima,Cholleti Sai Nikhith,Banerjee Sharmistha,Khan Nooruddin

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference61 articles.

1. 2009 update tuberculosis facts, world heal;Organ,2009

2. Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?;Moliva;Vaccine,2015

3. Y. Vila, N. Cavalcanti, M. Carolina, A. Brelaz, J. Kelle, D.A. Lemoine, C. Ferraz, A. Pereira, Role of TNF-Alpha, IFN-Gamma, and IL-10 in the Dev. Pulmonary Tuberculosis, 2012 (2015). https://doi.org/10.1155/2012/745483.

4. Understanding latent tuberculosis: a moving target;Lin;J. Immunol.,2010

5. A. O'Garra, P.S. Redford, F.W. McNab, C.I. Bloom, R.J. Wilkinson, M.P.R. Berry, The immune response in tuberculosis., 2013. https://doi.org/10.1146/annurev-immunol-032712-095939.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Specific Cytokines Analysis Incorporating Latency-Associated Antigens Differentiates Mycobacterium tuberculosis Infection Status: An Exploratory Study;Infection and Drug Resistance;2024-08

2. Immunogenic profiling of Mycobacterium tuberculosis Rv1513 reveals its ability to switch on Th1 based immunity;Archives of Microbiology;2024-07-16

3. Long-Term Immunogenicity and In Vitro Prophylactic Protective Efficacy of M. tuberculosis Fusion Protein DR2 Combined with Liposomal Adjuvant DIMQ as a Boosting Vaccine for BCG;ACS Infectious Diseases;2023-02-21

4. Progress in the Development of New Vaccines Against Tuberculosis;Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges;2023

5. Blue Skies research is essential for ending the Tuberculosis pandemic and advancing a personalized medicine approach for holistic management of Respiratory Tract infections.;International Journal of Infectious Diseases;2022-11